Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biocept Inc (BIOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3457
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Equity Offering 14
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc – Key Competitors 29
Biocept Inc – Key Employees 30
Biocept Inc – Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Biocept reports second quarter 2018 financial results 32
May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 35
Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 37
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 40
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 43
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 46
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 48
Corporate Communications 50
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Biocept Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biocept Enters into Research Agreement with University of Minnesota 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Biocept Enters into Partnership with Dana-Farber Cancer Institute 13
Biocept Raise USD11.6 Million in Rights Offering of Units 14
Biocept Plans to Raise USD50 Million in Public Offering of Securities 16
Biocept Prices Public Offering of Shares for USD3.3 Million 17
Biocept Prices USD3.3 Million in Public Offering of Shares 19
Biocept Plans to Raise Funds through Private Placement of Shares 20
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 21
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept to Raise USD15 Million in Public Offering of Shares 25
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 26
Biocept Completes IPO For US$19 Million 28
Biocept Inc, Key Competitors 29
Biocept Inc, Key Employees 30

List of Figures
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biocept Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biocept Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steppe Cement Ltd:企業の戦略・SWOT・財務情報
    Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Royal Bank Of Scotland Group Plc:企業の戦略・SWOT・財務分析
    The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank Of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • MenoGeniX Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MenoGeniX Inc (MenoGeniX) is a biopharmaceutical company that develops treatment for menopausal women and cancer patients. The company provides pipeline products portfolio such as MNGX-100, is under Phase 1b human clinical trial. Its therapeutic agents are developed for new indications such …
  • J.Crew Group, Inc.:企業の戦略・SWOT・財務情報
    J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Bank of Egypt S.A.E:企業の戦略・SWOT・財務情報
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SAS Institute Inc.:戦略・SWOT・企業財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …
  • Brooks MacDonald Group PLC (BRK)
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • MaaT Pharma:製薬・医療:M&Aディール及び事業提携情報
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also …
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Genmab AS (GEN):企業の財務・戦略的SWOT分析
    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • HOCHTIEF AG:戦略・SWOT・企業財務分析
    HOCHTIEF AG - Strategy, SWOT and Corporate Finance Report Summary HOCHTIEF AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Air France-KLM SA:企業の戦略・SWOT・財務情報
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Lepu Medical Technology (Beijing) Co Ltd (300003):製薬・医療:M&Aディール及び事業提携情報
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventio …
  • CMA CGM SA:企業の戦略・SWOT・財務情報
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Albany Molecular Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio drug discovery and development, manufacturing of Active Pharmaceutical Ingredients (API); process scale up development of fine chemicals and aseptic filling services for preclini …
  • ConocoPhillips:企業の戦略・SWOT・財務情報
    ConocoPhillips - Strategy, SWOT and Corporate Finance Report Summary ConocoPhillips - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Trevena Inc (TRVN)-製薬・医療分野:企業M&A・提携分析
    Summary Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆